Physician profile
Shari Mohammed
NPI 1659125243
$904.10
in general payments reported to CMS, 2019-2025
11 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $722 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.10 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $261.67 | 2024 | |
| Ucb, INC. | $133.32 | 2024-2025 | Bimzelx |
| Pfizer INC. | $125.00 | 2024 | |
| Janssen Biotech, INC. | $124.32 | 2024-2025 | Tremfya |
| Incyte Corporation | $65.00 | 2024-2025 | Opzelura |
| Lilly USA, LLC | $57.28 | 2024 | Taltz, Ebglyss, Olumiant |
| Exact Sciences Corporation | $32.24 | 2024 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $28.89 | 2024 | |
| Pharmaessentia USA Corporation | $28.60 | 2024 | Besremi |
| Karyopharm Therapeutics INC. | $26.28 | 2024 | Xpovio |
| Leo Pharma INC. | $21.50 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shari Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.